◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocks0-9 › 6922

Cryofocus Medtech (Shanghai) Co., Ltd. (6922) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Medical Devices · DATA UPDATED 2026-08-10

Cryofocus Medtech (Shanghai) Co., Ltd. (6922) operates in the Medical Devices industry and is headquartered in Shanghai, China with about 174 employees. Its market capitalization is roughly CNY 896 million. In the fiscal year ended 2025-12-31, 6922 reported CNY 95M in revenue and (CNY 38M) in net income.

Cryofocus Medtech (Shanghai) Co., Ltd., a medical device company, engages in the research, development, manufacture, and sale of cryoablation minimally invasive interventional treatment technology and related medical products in the People's Republic of China.

Interactive charts & full statements →

6922 Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total RevenueCNY 95MCNY 54MCNY 41MCNY 27M
Gross ProfitCNY 64MCNY 38MCNY 31MCNY 19M
Operating Income (EBIT)(CNY 43M)(CNY 111M)(CNY 108M)(CNY 121M)
Net Income(CNY 38M)(CNY 104M)(CNY 98M)(CNY 112M)

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

6922 Free Cash Flow History

6922 Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total AssetsCNY 138MCNY 149MCNY 213MCNY 314M
Total LiabilitiesCNY 89MCNY 70MCNY 39MCNY 54M

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 6922 viewer.

Other Companies in Medical Devices

← 6920All “0-9” companies6923 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.